Proteomics

Dataset Information

0

Quantitative phosphoproteomics unveils temporal dynamics of thrombin signaling in human endothelial cells


ABSTRACT: Thrombin is the key serine protease of the coagulation cascade and a potent trigger of protease-activated receptor (PAR)1-mediated platelet aggregation. In recent years, PAR1 has become an appealing target for anticoagulant therapies. However, the inhibitors that have been developed so far increase bleeding risk in patients, likely because they interfere with endogenous PAR1 signaling in the endothelium. Due to its complexity, thrombin-induced signaling in endothelial cells has remained incompletely understood. Here, we have combined stable isotope amino acids in cell culture, affinity-based phospho-peptide enrichment and high resolution mass spectrometry and performed a time-resolved analysis of the thrombin-induced signaling in human primary endothelial cells. We identified 2224 thrombin-regulated phosphorylation sites, the majority of which has not been previously related to thrombin. Those sites were localized on proteins which are novel to thrombin signaling, but also on well-known players such as PAR1, Rho-associated kinase 2, phospholipase C, and proteins related to actin cytoskeleton, cell-cell junctions and Weibel-Palade body release. Our study provides a unique resource of phosphoproteins and phosphorylation sites which may generate novel insights into an intimate understanding of thrombin-mediated PAR signaling and the development of improved PAR1 antagonists that affect platelet but not endothelial cell function.

REANALYSED by: PAe005425

INSTRUMENT(S): LTQ Orbitrap Elite

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Endothelial Cell, Blood

SUBMITTER: Sara Zanivan  

LAB HEAD: Sara Zanivan

PROVIDER: PXD000597 | Pride | 2014-02-06

REPOSITORIES: Pride

altmetric image

Publications

Quantitative phosphoproteomics unveils temporal dynamics of thrombin signaling in human endothelial cells.

van den Biggelaar Maartje M   Hernández-Fernaud Juan Ramon JR   van den Eshof Bart L BL   Neilson Lisa J LJ   Meijer Alexander B AB   Mertens Koen K   Zanivan Sara S  

Blood 20140205 12


Thrombin is the key serine protease of the coagulation cascade and a potent trigger of protease-activated receptor 1 (PAR1)-mediated platelet aggregation. In recent years, PAR1 has become an appealing target for anticoagulant therapies. However, the inhibitors that have been developed so far increase bleeding risk in patients, likely because they interfere with endogenous PAR1 signaling in the endothelium. Because of its complexity, thrombin-induced signaling in endothelial cells has remained in  ...[more]

Similar Datasets

2017-08-22 | PXD004264 | Pride
2019-11-20 | MSV000084604 | MassIVE
2024-11-27 | PXD052627 | Pride
2024-11-27 | PXD055122 | Pride
2021-04-01 | GSE171228 | GEO
2024-06-10 | GSE266395 | GEO
2023-03-01 | GSE204901 | GEO
2016-06-23 | PXD002554 | Pride
2022-08-24 | GSE211813 | GEO
2017-03-28 | MSV000080708 | MassIVE